Cochrane Abstracts
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Luteinising Hormone Releasing Hormone (LHRH) Agonists for the Treatment of Relapsed Epithelial Ovarian Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436254/all/Luteinising_hormone_releasing_hormone__LHRH__agonists_for_the_treatment_of_relapsed_epithelial_ovarian_cancer.
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436254/all/Luteinising_hormone_releasing_hormone__LHRH__agonists_for_the_treatment_of_relapsed_epithelial_ovarian_cancer. Accessed March 21, 2025.
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436254/all/Luteinising_hormone_releasing_hormone__LHRH__agonists_for_the_treatment_of_relapsed_epithelial_ovarian_cancer
Luteinising Hormone Releasing Hormone (LHRH) Agonists for the Treatment of Relapsed Epithelial Ovarian Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436254/all/Luteinising_hormone_releasing_hormone__LHRH__agonists_for_the_treatment_of_relapsed_epithelial_ovarian_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer
ID - 436254
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436254/all/Luteinising_hormone_releasing_hormone__LHRH__agonists_for_the_treatment_of_relapsed_epithelial_ovarian_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
